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Abstract
Background: Augmentation cystoplasty (AC) with autogenous ileum remains the current gold standard surgical treatment
for many patients with end-stage bladder disease. However, the presence of mucus-secreting epithelium within the bladder
is associated with debilitating long-term complications. Currently, decellularised biological materials derived from porcine
extracellular matrix (ECM) are under investigation as potential augmentation scaffolds. Important biomechanical limitations
of ECMs are decreased bladder capacity and poor compliance after implantation.
Methodology/Principal Findings: In the present ex vivo study a novel concept was investigated where a two-fold increase
in ECM scaffold surface-area relative to the resected ileal segment was compared in ovine bladder models after AC. Results
showed that bladder capacity increased by 4064% and 37611% at 10 mmHg and compliance by 40.464% and 39.766%
(DP= 0–10 mmHg) after AC with ileum and porcine urinary bladder matrix (UBM) respectively (p,0.05). Comparative
assessment between ileum and UBM demonstrated no significant differences in bladder capacity or compliance increases
after AC (p.0.05).
Conclusions: These findings may have important clinical implications as metabolic, infective and malignant complications
precipitated by mucus-secreting epithelium are potentially avoided after augmentation with ECM scaffolds.
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Introduction
The primary function of the urinary bladder is to store urine
between periods of voluntary voiding. However, a number of
pathological conditions such as multiple sclerosis, spinal cord injury,
and idiopathic urge incontinence may affect the bladder often
resulting in a poorly compliant, high-pressure storage reservoir.
After failing conservative and medical therapies patients with these
conditions often need surgical intervention with augmentation
cystoplasty (AC). AC is the addition of viscoelastic autogenous
gastrointestinal tissue to the bladder to increase capacity, improve
compliance, or decrease detrusor overactivity. AC has replaced
cutaneous urinary diversion as the gold standard surgical treatment
in this group of patients because of decreased morbidity and
improved quality of life. Long-term disadvantages of AC include
recurrent urinary tract infections (UTIs), bladder calculi, metabolic
disturbances and a predisposition to malignancy [1].
On account of these complications, researchers have recently
attempted to use alternative augmentation strategies by applying
tissue-engineered extracellular matrix (ECM) scaffolds in place of
autogenous gastrointestinal tissue [2,3]. ECMs are decellularised,
biodegradable membranes usually derived from porcine organs
[4]. Furthermore, post-operative inflammatory reactions are
avoided with ECMs due to their acellular inert nature [5].
Urinary bladder matrix (UBM) is an ECM that is sourced from the
porcine bladder and it induces a host derived regenerative
response after surgical implantation [6]. Replacing autogenous
ileum with UBM for bladder augmentation purposes may have the
advantages of fewer long-term metabolic, infective and malignant
complications while negating autogenous ileal resection.
Despite the perceived functional advantages of ECMs compared
to autogenous ileum, significant biomechanical limitations occur
when ECM is applied in urological settings. Postoperatively,
bladder capacity and compliance remain significantly lower than
values achieved with more compliant ileal segments [7,8]. To
prevent these biomechanical complications from occurring, it may
be necessary to increase the ECM scaffold surface-area, relative to
the surface-area of detubularised ileum, if comparable capacity and
compliance values are to be achieved after AC [9]. The aim of the
present ex vivo study was to determine the relative increase in ECM
scaffold surface-area required for achieving comparable bladder
capacity values with ileum after AC in ovine bladder models.
Materials and Methods
2.1 Ethics statement
All animal tissue was obtained from an abattoir (Gaelic Meats,
Patrickswell, Limerick, Ireland) immediately after euthanasia.
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Ethical approval for ex vivo tissue culture was approved by the
University of Limerick’s ethics approvals process.
2.2 Overview of experimental design
Urinary bladders and distal ileum of 17 female lambs, all 7
months old, were sourced from an abattoir (Gaelic Meats,
Patrickswell, Limerick, Ireland) immediately after euthanasia.
Porcine UBM was received from the McGowan Institute of
Regenerative Medicine, University of Pittsburgh, and all other
materials were obtained from CABER (Centre for Applied
Biomedical Engineering Research, Limerick, Ireland) unless
indicated. Four bladders were used for comparative tensile testing
purposes with ileum and UBM. One control bladder was used to
determine the relative surface-area ratio of UBM to ileum for
achieving comparable bladder capacity values after AC. To
validate our ‘surface-area’ concept the remaining 12 bladders
underwent AC; 6 had AC with detubularised ileum (565 cm) and
6 had AC with a larger (866.5 cm) UBM scaffold. The primary
endpoint of the study was to compare bladder capacity and
compliance in both AC groups.
2.3 Biomechanical testing
Strips of bladder tissue were resected along the bladder’s
longitudinal axis and measured 30 mm69.3 mm61.560.29 mm
in length, width and thickness respectively. Three strips were
obtained from each bladder and 12 strips were prepared for tensile
testing purposes. Strips of autogenous detubularised ileum were
resected along the longitudinal axis of the small bowel and
measured 40 mm69.3 mm60.3560 mm (n= 12). Strips of UBM
measured 40 mm69.3 mm60.2060 mm and were prepared for
comparative analysis (n = 12). Each material was cut into a dog-
bone shape (with a steel template) and maintained in tissue
transport medium at 37uC (Dulbecco’s phosphate buffered saline,
InnoprotH, Bizkaia, Spain). Tensile testing was performed by
clamping each prepared specimen into a custom fabricated tensile
tester with a 50 N load cell (MecmesinH, Newton House, Spring
Copse Business Park, Slinfold, West Sussex, United Kingdom). An
incremental strain rate of 1 mm/s was applied to each clamped
tensile specimen and the magnitude of the load (N) was measured
in Newtons. Extension data and load obtained during the testing
period were converted to stress (s) and strain (e) values.
2.4 Measurement of baseline bladder capacity and
compliance
The urinary bladder and both ureters of each ovine model was
identified, mobilised and explanted through dissection techniques.
Each explanted bladder was maintained in tissue transport
medium (Dulbecco’s phosphate buffered saline, InnoprotH,
Bizkaia, Spain) and transported to the laboratory on ice
immediately after euthanasia. A ‘pressure/ volume’ rig was
constructed based on previously described methodology [9]. Each
bladder was connected to the rig after emptying all intravesical
contents and ligating both ureters. Air was then fed into a fluid-
filled vessel at a constant rate via an air line. This resulted in an
increase in hydrostatic pressure within the vessel and allowed fluid
to flow into each urinary bladder via the urethral orifice at a
controlled physiological flow rate of 0.5 ml/min (Fig. 1). Bladder
capacity was recorded at 2, 4, 6, 8 and 10 mmHg by measuring
the volume (V) of infused fluid at each pressure (P) measurement.
Compliance (C) was measured by dividing the volume changes by





Where: C= compliance, DV= change in volume, DP= change
in pressure.
2.5 Preparation of UBM grafts
Preparation of UBM has previously been described [11].
Briefly, the inner urothelial layers are removed by submerging
the harvested porcine bladder in normal saline. The outer tunica
serosa, tunica muscularis externa, tunica submucosa and muscu-
laris mucosa are then manually delaminated from the bladder.
Figure 1. Schematic of ovine bladder connected to pressure/volume rig at 10 mmHg via the urethral orifice. The filling rate into the
bladder was 0.5 ml/min and bladder capacity was recorded at 2, 4, 6, 8 and 10 mmHg by measuring the volume (ml) of infused fluid at each pressure
(mmHg) measurement.
doi:10.1371/journal.pone.0020323.g001
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The remaining basement membrane of the tunica epithelialis
submucosa and subjacent tunica propria is termed UBM. Finally,
the decellularisation process is completed by soaking the UBM
scaffold in buffered saline (pH 7.4), placing it in peracetic acid/4%
ethanol for 2 hours and rinsing it in sterile buffered saline.
Manufacture of the 4-ply sheets is performed by moisture
extraction and a vacuum-pump compression technique.
2.6 Surface-area ratio of UBM to ileum required for
augmentation cystoplasty
To calculate the surface-area ratio of UBM to ileum, baseline
bladder capacity was measured in a control bladder at 2 mmHg.
AC with 25 cm2 of detubularised ileum was performed on the
control and percentage increases in capacity were recorded at
2 mmHg (Table1). Subsequently, AC was performed on the
control with 5 UBM grafts that increased in surface-area from
20 cm2 to 80 cm2. Percentage increases in capacity after AC with
UBM (surface-area ranges: 20–80 cm2) were recorded at 2 mmHg
and compared with ileum. Analysis of the data demonstrated that
AC with a 50 cm2 UBM scaffold resulted in a 40.7% increase in
capacity compared to an increase 40.0% with 25 cm2 of
detubularised ileum at 2 mmHg (Table 1).
2.7 Augmentation cystoplasty
A two-fold increase in UBM surface-area (50 cm2) relative to
autogenous ileum (25 cm2) demonstrated comparable increases in
bladder capacity after AC with both materials (see methods section
2.6 and table 1). Hence, 50 cm2 UBM scaffolds were applied to
ovine bladders for comparative purposes with ileum after AC.
2.7.1 Augmentation cystoplasty with ileum. For the
ileocystoplasty technique a 5 cm segment of ileum was resected
and detubularised along its antimesenteric border to form a
565 cm ileal sheet (n = 6). The bladder was then bivalved
horizontally for 5 cm along its apex and the detubularised ileum
was sutured to the bladder using a running 3–0 polyglactin suture
(Fig. 2a). Water tightness of the anastamosis was confirmed by
infusing saline via the urethral orifice.
2.7.2 Augmentation cystoplasty with UBM. Sheets of
four-ply UBM scaffolds measuring 866.5 cm (50 cm2) were pre-
hydrated in normal saline for 45 min at 37uC (n= 6). The
bladder was then bivalved 5 cm horizontally along is apex. UBM
was fixed to the urinary bladder using a running 3–0 polyglactin
suture and oriented such that its basement membrane faced the
luminal surface of the bladder (Fig. 2b). Water-tightness of the
anastomosis was confirmed by injecting saline via the urethral
orifice.
2.8 Measurement of bladder capacity and compliance in
augmented bladders
Bladders augmented with autogenous ileum and UBM were
connected to the pressure/volume rig and bladder capacity was
measured at 2, 4, 6, 8, and 10 mmHg. Initially, capacity in both
augmented groups was compared with baseline values (i.e. capacity
prior to AC). Capacity values in both augmented groups were then
compared with one another. Subsequently, compliance values at
10 mmHg in both augmented groups was calculated and compared
by dividing pressure changes by relative volume changes (DV/DP).
2.9 Statistical analysis
Data was expressed as a mean 6 standard deviation. Statistical
analysis was performed using a one-factor analysis of variance
(ANOVA). Student t-tests with unequal variances were performed
for pairwise comparisons. Differences were considered significant
at p,0.05 (SPSS 16.0 for Windows).
Results
3.1 Biomechanical tensile testing for bladder, ileum and
UBM
Stress-strain curves between bladder tissue, ileal tissue and
UBM were constructed based on average data as illustrated in
figure 3. Strain to failure occurred at 26.266.1% in UBM, at
42.265.2% in ileum and at 128.3610% in bladder tissue
(p,0.01). Linear stiffness ‘E’ at 30% strain measured 0.0666
0.03 MPa for bladder tissue compared to 0.6760.32 MPa and
16.462.51 MPa for ileum and UBM respectively (p,0.01).
Table 2 compares the mechanical characteristics of all 3 materials
assessed in the study.
3.2 Augmentation cystoplasty with ileum
Baseline and ileocystoplasty capacity values are summarised in
Table 3. Baseline capacity values ranged from 125617 ml at
2 mmHg to 240645 ml at 10 mmHg and ileocystoplasty values
ranged from 175625 ml at 2 mmHg to 336656 ml at 10 mmHg.
Ovine bladders that underwent AC with autogenous ileum
demonstrated a significant increase in bladder capacity at 2, 4,
6, 8 and 10 mmHg (Fig. 4a, p,0.01). Volumetric increases ranged
from 5169 ml at 2 mmHg to 96613 ml at 10 mmHg. Bladder
compliance measured at 10 mmHg was also significantly increased
after AC with ileum (40.464%, p,0.01). Compliance values
ranged from 2465 ml/mmHg at baseline (DP= 0–10 mmHg) and
increased to 3466 ml/mmHg (DP= 0–10 mmHg) post AC with
ileum (Table 4).
Table 1. Calculating the surface-area ratio of UBM to ileum after AC in a control bladder.
Ileum UBM 1 UBM 2 UBM 3 UBM 4 UBM 5
Volume at 2 mmHg (ml) 105 105 105 105 105 105
Dimension of applied graft for AC (cm) 565 564 665 765.725 866.5 1068
Surface area of applied graft (cm2) 25 20 30 40 50 80
Surface area ratio of ileum to UBM - 1:0.8 1:1.2 1:1.6 1:2 1:3.2
Percentage increase in capacity (%) 40.0 23.9 32.3 37.5 40.7 50.0
AC, augmentation cystoplasty.
AC was initially performed with ileum (25 cm2) and percentage increases in capacity were recorded at 2 mmHg. Subsequently, AC was performed on the control with
UBM scaffolds ranging from 20 cm2 to 80 cm2 and percentage increases were compared at 2 mmHg to ileal values. AC with an 866.5 cm (50 cm2) UBM scaffold
resulted in a 40.7% increase in bladder capacity compared to an increase of 40.0% with a 565 cm (25 cm2) of detubularised ileum at 2 mmHg. Hence, 50 cm2 UBM
scaffolds were applied to ovine bladders for comparative purposes with ileum after AC.
doi:10.1371/journal.pone.0020323.t001
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3.3 Augmentation cystoplasty with UBM
Baseline and UBM-cystoplasty capacity values are summarised
in Table 5. Baseline bladder capacities in the group undergoing
AC with UBM were greater than the ileocsystoplasty group;
however these differences were not statistically significant (p.0.1).
Baseline values in the second group ranged from 139614 ml at
2 mmHg to 266652 ml at 10 mmHg. Capacity values were
significantly increased after augmentation with UBM and
volumetric increases ranged from 52616 ml at 2 mmHg to
100625 ml at 10 mmHg (Fig. 4b, p,0.05). Compliance at DP of
0–10 mmHg was also increased after AC with UBM (39.766%) in
comparison to baseline. Compliance values ranged from
2565 ml/mmHg (DP= 0–10 mmHg) to 3567 ml/mmHg
(DP= 0–10 mmHg) post AC with UBM (Table 5, p,0.02).
3.4 Comparison of bladder capacity and compliance in
both augmented groups
Comparisons of bladder capacity characteristics between both
groups that underwent AC are summarised in Table 6. Ovine
models undergoing AC with autogenous ileum showed a
volumetric increase of 96613 ml at 10 mmHg whereas models
that underwent AC with UBM demonstrated an increase of
100625 ml (p.0.5). Percentage increases in bladder capacity
were greater in ovine models that underwent AC with ileum
compared to AC with UBM and ranged from 3612% at 2 mmHg
to 165% at 10 mmHg, however these values were not statistically
significant (Fig. 5, p.0.5). Compliance increases at 10 mmHg
were also greater, but not statistically significant, in ovine models
undergoing AC with ileum compared to AC with UBM (40.464%
versus 39.766%); (Table 4, p.0.8).
Discussion
Bladder augmentation with tissue-engineered ECM scaffolds is
challenged by the urinary bladder’s unique biomechanical
properties. An ideal augmentation scaffold should accommodate
large changes in intravesical volume while maintaining almost
constant pressure values. Autogenous ileum possesses relatively
similar biomechanical properties and has therefore remained the
gold standard replacement material since initially described almost
100 years ago [12]. In the present ex vivo study we compared AC
using UBM with detubularised ileum in an ovine model.
Important findings were that AC with UBM resulted in a
significant increase in bladder capacity and compliance compared
to baseline values. Furthermore, percentage increases in capacity
and compliance were comparable in both experimental groups
when a two-fold increase in ECM scaffold surface-area (50 cm2)
relative to the resected ileal segment (25 cm2) was applied.
Figure 2. Augmentation cystoplasty with autogenous distal ileum (A) and UBM (B). For the ileocystoplasty the apex of the bladder was
bivalved horizontally for 5 cm and detubularised ileum (565 cm) was sutured to the bladder (A). For the UBM-cystoplasty the bladder was bivalved
5 cm horizontally along is apex and four-ply UBM (866.5 cm) was sutured to the bladder (B).
doi:10.1371/journal.pone.0020323.g002
Figure 3. Comparative uni-axial tensile testing between UBM,
ileum and bladder tissue. Strips of UBM (40 mm 69.3 mm 6
0.2060 mm), ileum (40 mm 69.3 mm 60.3560 mm) and bladder
tissue (30 mm69.3 mm61.560.29 mm) were loaded into the tensile
tester and an incremental extension rate of 1 mm/s was applied.
Extension data and load obtained during the testing period were
converted to stress (s) and strain (e) values for comparative analysis.
doi:10.1371/journal.pone.0020323.g003
Table 2. Comparative assessment of uni-axial tensile testing
results between UBM, ileum and bladder tissue (*p,0.001).
Parameters UBM Ileum Bladder
Failure Strength (MPa)* 8.2360.776 1.8160.47 0.61260.14
Failure Strain* 26.266.1% 42.265.2% 128.3610.0%
Linear Stiffness ‘E’ at 30% strain
(MPa)*
16.46 2.51 0.6760.32 0.06660.034
Failure Load (N)* 15.3461.49 5.1661.15 8.5361.87
Failure Extension (mm)* 10.7762.55 17.7862.46 44.1665.13
doi:10.1371/journal.pone.0020323.t002
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To the authors’ knowledge this is the first study comparing
UBM with gold-standard autogenous ileum specifically for the
purpose of bladder augmentation. A two-fold increase in ECM
surface-area was selected based on comparative analysis of volume
(ml)/ surface-area (cm2) ratios after AC was performed with ileum
and 5 UBM scaffolds (varying in surface area from 20–80 cm2) on
a control bladder model. Analysis of this preliminary data
demonstrated that AC with a 50 cm2 UBM scaffold resulted in
a 40.7% increase in capacity compared to an increase of 40.0%
with 25 cm2 (565 cm) of detubularised ileum. Admittedly, human
patients often require 15 cm of autogenous ileum to significantly
increase bladder capacity after AC; however ovine bladder
capacities are lower than human capacities by a ratio of 3:1
[13]. Hence, 5 cm ileal segments were applied to accommodate
this ratio. After AC percentage increases in bladder capacity were
comparable between UBM (39.766% at 10 mmHg) and ileum
(4064% at 10 mmHg). These findings may have important
clinical implications as metabolic, infective and malignant
complications precipitated by mucus-secreting epithelium are
potentially avoided after augmentation with UBM.
Previously, ECMs applied for bladder reconstruction have been
regular quadrilateral with 4 equal sides (e.g. 565 cm) [7,14].
Importantly, rectangular dimensions (866.5 cm) were selected in
the current study based on recent investigations by Parekh et al.where
deformations of the rat bladder were assessed ex vivo during the filling
process [15]. In their study it was demonstrated that bladder tissue
remains stiffer in the circumferential direction compared to the
longitudinal direction in passive and inactive states (2.3 and 1.9 peak
stretch values longitudinally and circumferentially respectively).
These findings infer a peak stretch ratio of 1:0.8 in favour of the
longitudinal direction as the bladder fills. To comply with this
longitudinal strain-path to filling, rectangular UBM scaffolds were
constructed and implanted in favour of the longitudinal direction
(1:0.8). In the future, we hope to further refine our implantation
technique by characterising the major axis of each four-ply UBM
scaffold prior to AC This may be achievable by resecting a segment
from each multilaminate UBM scaffold prior to surgical implantation
and performing bi-axial tensile testing on the resected portion.
It is well established that ECMs possess a number of noteworthy
advantages for urological tissue-engineering purposes. Surface-
area increases with ECMs are easily achieved due to their
xenogenic, readily available nature in comparison to the often
restricted availability of autogenous gastrointestinal tissue [13,16].
After application to the genitourinary tract ECM stimulates a host-
derived tissue remodeling response while undergoing simultaneous
degradation processes [6]. During the remodeling process
activated growth factors are released from their proteoglycans to
promote tissue neovascularisation and host-cell deposition. In
addition, studies have demonstrated that ECMs are rapidly
degraded after implantation into the genitourinary tract with
90% of the scaffold replaced by host tissue within 28 days of
implantation [17,18]. Inevitably, the process may be prolonged
(e.g.90–120 days) when multilaminate ECM scaffolds are
Figure 4. Comparative illustration of bladder capacity (ml) at baseline and after AC with ileum (A) and UBM (B). AC, augmentation
cystoplasty.
doi:10.1371/journal.pone.0020323.g004
Table 3. Bladder capacity characteristics before and after AC
with ileum (565 cm) at increasing pressures.
Pressure (mmHg) 2 4 6 8 10
Pre-AC with ileum
(ml)
125617 155625 188634 225642 240645
Post-AC with ileum
(ml)
175625 221635 269644 316657 336656
Volumetric increase
(ml)*
5169 66613 82612 92615 96613
Percentage increase
(%)*
4064 4367 4467 4164 4064
AC, augmentation cystoplasty.
Volumetric increases after ileocystoplasty ranged from 5169 ml at 2 mmHg to
96613 ml at 10 mmHg (*p,0.01, n = 6).
doi:10.1371/journal.pone.0020323.t003
Table 4. Comparative assessment of compliance values in
both groups before and after AC.
Bladder Compliance (ml/
mmHg) Ileum UBM ‘p’ value
Pre-AC (ml/mmHg) 2465 2565 -
Post-AC (ml/mmHg) 3466 3567 ,0.02*
Percentage Increase (%) (p{) 40.464 39.766 (.0.8{)
AC, augmentation cystoplasty.
Compliance values were obtained by dividing volume changes by their relative
pressure changes at 10 mmHg. Values were also compared between both
groups after AC.
*Comparing baseline compliance values with values post AC in both groups.
{Comparing percentage increases in compliance between ileum and UBM.
doi:10.1371/journal.pone.0020323.t004
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implanted. After the degradation process ECM scaffolds enter the
blood stream and are eventually excreted in the host’s urine as
demonstrated in one study where the excretion rate of 14C labeled
ECM was measured in a canine model. Results from this study
demonstrated 95% of the scaffold’s degradation products were
found in the host’s urine during the follow up period [18].
However, it is noteworthy that ECMs demonstrate a significant
decrease in mechanical strength after implantation due to a
temporal imbalance between the rate of scaffold degradation and
host cell deposition [5]. This temporal mismatch shifts in favour of
the degradation rate and greatly contributes to postoperative
complications such as poor compliance, decreased bladder
capacity and significantly impaired renal function. Complications
of this nature may persist unabated until the remodelling response
has been completed after 90–120 days [7,19]. Preliminary studies
in our laboratory have demonstrated that an increase in ECM
surface-area relative to its intended bladder defect may prevent
these complications by increasing the storage reservoir of the
bladder [9]. Intuitively, an increase in the bladder’s storage reserve
provides the potential for increased capacity at physiological
bladder pressures.
Our initial mechanical testing was performed based on previous
described methodology and our results clearly demonstrate the
relative stiffness of UBM (16.462.51% strain to failure) compared
to autogenous ileum and bladder tissue (0.6760.32% and
0.06660.034% strain to failure respectively, p,0.01) [20,21,22].
To compensate for UBM’s stiff nature we sought to develop our
‘surface-area’ concept and assess its clinical potential specifically
for bladder augmentation purposes. Typically, AC involves an
incision along the apex of the bladder and augmentation of the
incised surfaces with a suitable biomaterial or scaffold. Recently,
investigators have focussed on more appealing, complicated and,
perhaps, rewarding applications for ECMs in reconstructive
urology. In the field of regenerative medicine, partial or complete
bladder reconstruction with ECM has gained widespread interest
among many research groups. Arguably, the strong focus on
complete organ reconstruction has meant that ECMs have been
overlooked as effective candidates for bladder augmentation. A
paucity of literature is available on AC with ECMs, however one
recent study by Wang et al. assessed AC with autogenous ileum
and small intestinal submucosa (SIS) in a porcine model [19].
Findings from their study demonstrated greater capacity increases
in bladder’s augmented with ileum (211 ml) compared to SIS
(144.3 ml) after a 6 week experimental time period. Interestingly,
the surface-area of ileal and ECM scaffolds applied for AC were
equivalent. It is likely that comparable bladder capacity increases
between both groups may have been achieved if increases in SIS
scaffold surface-area relative to detubularised ileum were applied
intraoperatively.
Currently, a variety of biomaterials are commercially available
for regenerative and reconstructive purposes across numerous
surgical subspecialties. UBM was selected for AC in this study
based on notable biomechanical and biological advantages over
other ECM scaffolds. Native bladder tissue is mildly anisotropic in
response to large intravesical volume increases and remains stiffer
along its circumferential axis compared to its longitudinal axis
[15]. Recent studies have demonstrated that this in vivo stretch
response is retained by UBM after the decellularisation process
[23]. Conversely, decellularised porcine small intestinal submucosa
(SIS) is strongly anisotropic as spirally arranged collagen fibers
stretch and constrict along their longitudinal axis in a manner
similar to gastrointestinal peristalsis [24]. Interestingly, UBM
uniquely retains an intact basement membrane [11] and this
advantageous feature can partially contribute to the prevention of
urine infiltrating deeper into tissues while supporting growth and
differentiation of multilayered urothelial cells in vivo [25]. Finally, in
vitro studies have recently demonstrated that UBM’s biocompa-
tibily is significantly better than SIS’s when culturing human
urothelial cells on its luminal surface prior to in vivo implantation
[26].
The present study is not without limitations and our results must
be viewed with caution. Due to its ex vivo nature long-term clinical
sequelae of AC with larger UBM scaffolds were not addressed. An
in vivo study with appropriate pre- and postoperative urodynamic
studies would be required to accurately assess functional bladder
Table 5. Bladder capacity characteristics at before and after
AC with UBM (866.5 cm) at increasing pressures.
Pressure (mmHg) 2 4 6 8 10
Pre-AC with UBM (ml) 140614 174622 210635 234648 266652
Post-AC with UBM (ml) 192625 239640 292665 324679 352674
Volumetric increase (ml)* 52616 65626 83634 90636 100625
Percentage increase (%)* 37611 37614 39613 38612 3966
AC, augmentation cystoplasty.
Volumetric increases after AC with UBM ranged from 52616 ml at 2 mmHg to
100625 ml at 10 mmHg. Percentage increases in capacity ranged from
37611% at 2 mmHg to 3966% at 10 mmHg (*p,0.02, n = 6).
doi:10.1371/journal.pone.0020323.t005
Figure 5. Comparative illustration of percentage increases in
bladder capacity after AC with ileum and UBM. Bladder capacity
increases were not statistically significant at 2, 4, 6, 8 and 10 mmHg
when AC with ileum (565 cm) was compared with UBM (866.5 cm),
(p.0.5). AC, augmentation cystoplasty.
doi:10.1371/journal.pone.0020323.g005
Table 6. Comparative assessment of percentage increases in
bladder capacity at increasing pressures after AC was
performed with ileum and UBM.
Pressure (mmHg) 2 4 6 8 10
AC with ileum (% increase) 4064 4367 4467 4164 4064
AC with UBM (% increase) 37611 37614 39613 38612 3966
Percentage Difference (%)* 3612 6617 5614 3611 165
AC, augmentation cystoplasty.
Percentage increases in capacity were greater in ovine models that underwent
AC with ileum compared to UBM and ranged from 3612% at 2 mmHg to 165%
at 10 mmHg. These values were not statistically significant (*p.0.5).
doi:10.1371/journal.pone.0020323.t006
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capacity and effective host-cell infiltration of UBM during the
follow-up period. Based on the results of the present study we are
currently in the process of designing an in vivo study of this nature.
Importantly, recent reports describing residual porcine DNA on
ECM’s after their preparation processes have inevitably led to
concerns over in vivo biocompatibility [27]. Standardised and
thorough decellularistion techniques need to be adopted by
researchers to promote host biocompatibility after implantation
of the scaffold [16]. It can also be argued that fatigue properties of
ex vivo bladder and ileal tissue may have biased our capacity results
in favour of UBM after AC. However, a number of recent studies
have demonstrated that bladder tissue retains its visocoelastic
properties and produces reliable results when investigating
capacity for up to 48 hours post mortem. To eliminate this
potential bias all investigations in the present study were carried
out within 6 hours of euthanasia.
ECM scaffolds possess important biological advantages when
compared to mucus-secreting ileal tissue for bladder augmenta-
tion; however their biomechanical limitations need to be addressed
and resolved prior to clinical implementation. In this study we
investigated a novel concept where a two-fold increase in ECM
scaffold surface-area relative to the resected ileal segment was
applied for bladder augmentation in ovine bladder models. Our
results demonstrated that this surface-area increase leads to
comparable bladder capacity increases after AC. Knowledge
obtained from this study provides evidence that ECM scaffolds are
an attractive alternative to autogenous gastrointestinal tissue for
bladder augmentation purposes.
Acknowledgments
We are thankful to Professor Stephen F. Badylak, McGowan Institute for
Regenerative Medicine, University of Pittsburgh, for providing us with the
UBM scaffolds for this study.
Author Contributions
Conceived and designed the experiments: ND RM AC HF. Performed the
experiments: ND RM. Analyzed the data: AC TMcG. Contributed
reagents/materials/analysis tools: ND RM AC HF TMcG. Wrote the
paper: ND RM AC.
References
1. Flood HD, Malhotra SJ, O’Connell HE, Ritchey MJ, Bloom DA, et al. (1995)
Long-term results and complications using augmentation cystoplasty in
reconstructive urology. Neurourol Urodyn 14: 297–309.
2. Sharma AK, Hota PV, Matoka DJ, Fuller NJ, Jandali D, et al. (2010) Urinary
bladder smooth muscle regeneration utilizing bone marrow derived mesenchy-
mal stem cell seeded elastomeric poly(1,8-octanediol-co-citrate) based thin films.
Biomaterials 31: 6207–6217.
3. Ayyildiz A, Nuhoglu B, Huri E, Ozer E, Gurdal M, et al. (2006) Using porcine
acellular collagen matrix (Pelvicol) in bladder augmentation: experimental study.
Int Braz J Urol 32: 88–92. discussion 92-83.
4. Shaikh FM, O’Brien TP, Callanan A, Kavanagh EG, Burke PE, et al. (2010)
New pulsatile hydrostatic pressure bioreactor for vascular tissue-engineered
constructs. Artif Organs 34: 153–158.
5. Gilbert TW, Stewart-Akers AM, Simmons-Byrd A, Badylak SF (2007)
Degradation and remodeling of small intestinal submucosa in canine Achilles
tendon repair. J Bone Joint Surg Am 89: 621–630.
6. Badylak SF (2007) The extracellular matrix as a biologic scaffold material.
Biomaterials 28: 3587–3593.
7. Zhang Y, Frimberger D, Cheng EY, Lin HK, Kropp BP (2006) Challenges in a
larger bladder replacement with cell-seeded and unseeded small intestinal
submucosa grafts in a subtotal cystectomy model. BJU Int 98: 1100–1105.
8. Davis NF, McGuire BB, Callanan A, Flood HD, McGloughlin TM (2010)
Xenogenic extracellular matrices as potential biomaterials for interposition
grafting in urological surgery. J Urol 184: 2246–2253.
9. Davis NF, Callanan A, McGuire BB, Mooney R, Flood HD, et al. (2011)
Porcine extracellular matrix scaffolds in reconstructive urology: An ex vivo
comparative study of their biomechanical properties. J Mech Behav Biomed
Mater 4: 375–382.
10. Wahl EF, Lerman SE, Lahdes-Vasama TT, Churchill BM (2004) Measurement
of bladder compliance can be standardized by a dimensionless number: clinical
perspective. BJU Int 94: 898–900.
11. Brown B, Lindberg K, Reing J, Stolz DB, Badylak SF (2006) The basement
membrane component of biologic scaffolds derived from extracellular matrix.
Tissue Eng 12: 519–526.
12. Neuhof H (1917) Facial transplantation into visceral defects: an experimental
and clinical study. Surg Gynecol Obst 25: 383.
13. Rink RC, Mitchell ME (1990) Role of enterocystoplasty in reconstructing the
neurogenic bladder; Gonzales ETRD, ed. St. Louis: Mosby–Year Book.
14. Atala A, Bauer SB, Soker S, Yoo JJ, Retik AB (2006) Tissue-engineered
autologous bladders for patients needing cystoplasty. Lancet 367: 1241–1246.
15. Parekh A, Cigan AD, Wognum S, Heise RL, Chancellor MB, et al. (2010) Ex
vivo deformations of the urinary bladder wall during whole bladder filling:
Contributions of extracellular matrix and smooth muscle. J Biomech.
16. Gilbert TW, Sellaro TL, Badylak SF (2006) Decellularization of tissues and
organs. Biomaterials 27: 3675–3683.
17. Kropp BP, Rippy MK, Badylak SF, Adams MC, Keating MA, et al. (1996)
Regenerative urinary bladder augmentation using small intestinal submucosa:
urodynamic and histopathologic assessment in long-term canine bladder
augmentations. J Urol 155: 2098–2104.
18. Record RD, Hillegonds D, Simmons C, Tullius R, Rickey FA, et al. (2001) In
vivo degradation of 14C-labeled small intestinal submucosa (SIS) when used for
urinary bladder repair. Biomaterials 22: 2653–2659.
19. Wang DS, Anderson DA, Fretz PC, Nguyen TT, Winfield HN (2007)
Laparoscopic augmentation cystoplasty: a comparison between native ileum
and small intestinal submucosa in the porcine model. BJU Int 99: 628–631.
20. Coburn JC, Brody S, Billiar KL, Pandit A (2007) Biaxial mechanical evaluation
of cholecyst-derived extracellular matrix: a weakly anisotropic potential tissue
engineered biomaterial. J Biomed Mater Res A 81: 250–256.
21. Freytes DO, Stoner RM, Badylak SF (2008) Uniaxial and biaxial properties of
terminally sterilized porcine urinary bladder matrix scaffolds. J Biomed Mater
Res B Appl Biomater 84: 408–414.
22. Freytes DO, Badylak SF, Webster TJ, Geddes LA, Rundell AE (2004) Biaxial
strength of multilaminated extracellular matrix scaffolds. Biomaterials 25:
2353–2361.
23. Gilbert TW, Wognum S, Joyce EM, Freytes DO, Sacks MS, et al. (2008)
Collagen fiber alignment and biaxial mechanical behavior of porcine urinary
bladder derived extracellular matrix. Biomaterials 29: 4775–4782.
24. Sacks MS, Gloeckner DC (1999) Quantification of the fiber architecture and
biaxial mechanical behavior of porcine intestinal submucosa. J Biomed Mater
Res 46: 1–10.
25. Liu Y, Bharadwaj S, Lee SJ, Atala A, Zhang Y (2009) Optimization of a natural
collagen scaffold to aid cell-matrix penetration for urologic tissue engineering.
Biomaterials 30: 3865–3873.
26. Davis NF, Callanan A, McGuire BB, Flood HD, McGloughlin TM (2011)
Evaluation of Viability and Proliferative Activity of Human Urothelial Cells
Cultured Onto Xenogenic Tissue-Engineered Extracellular Matrices. Urology,
Jan 20.
27. John TT, Aggarwal N, Singla AK, Santucci RA (2008) Intense inflammatory
reaction with porcine small intestine submucosa pubovaginal sling or tape for
stress urinary incontinence. Urology 72: 1036–1039.
Cystoplasty and Extracellular Matrix Scaffolds
PLoS ONE | www.plosone.org 7 May 2011 | Volume 6 | Issue 5 | e20323
